KMT2A and acute lymphoblastic leukemia: Cytogenetic and molecular studies were performed to evaluate for high-risk features, particularly rearrangements involving the KMT2A gene (formerly MLL), which are frequently seen in infant ALL and are associated with poor prognosis.